Paving the way for patient centricity in real-world evidence (RWE): Qualitative interviews to identify considerations for wider implementation of patient-reported outcomes in RWE generation

Author:

Maruszczyk KonradORCID,McMullan ChristelORCID,Aiyegbusi Olalekan LeeORCID,Keeley Thomas,Wilson RogerORCID,Collis Philip,Bottomley Catherine,Calvert Melanie J.ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference67 articles.

1. Examining the use of real-world evidence in the regulatory process;Beaulieu-Jones;Clin. Pharmacol. Ther.,2020

2. Using real-world data in the health technology assessment of pharmaceuticals: strengths, difficulties, and a pragmatic way forward;Akehurst;Value Health,2023

3. Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU-actions for stakeholders;Facey;Int. J. Technol. Assess. Health Care,2020

4. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions;Wu;Pharmacoepidemiol. Drug Saf.,2020

5. Real-world evidence-current developments and perspectives;Schad;Int. J. Environ. Res. Publ. Health,2022

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3